Accretion Pharmaceuticals Limited (NSE:ACCPL)
India
· Delayed Price · Currency is INR 68.65
+3.20 (4.89%)
At close: Mar 10, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 763.11 million as of March 10, 2026.
Market Cap
763.11M
Enterprise Value
840.11M
Revenue
826.43M
Ranking
n/a
PE Ratio
6.99
Stock Price
68.65
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has decreased from 922.07M to 763.11M, a decrease of -17.24%. That is a compound annual growth rate of -21.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 727.54M | -25.50% |
| Dec 31, 2025 | 976.54M | 5.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amwill Health Care | 717.13M |
| Asston Pharmaceuticals | 685.29M |
| Source Natural Foods and Herbal Supplements | 809.77M |
| Makers Laboratories | 838.74M |
| Godavari Drugs | 625.18M |
| Onyx Biotec | 598.36M |
| Mercury Laboratories | 930.06M |
| Phaarmasia | 558.85M |